Evidence map›Paper›PMID 26250903›Full record

ArticleCritical care (London, England)2015

Hyperdynamic left ventricular ejection fraction in the intensive care unit.

Joseph R Paonessa, Thomas Brennan, Marco Pimentel, Daniel Steinhaus, Mengling Feng, Leo Anthony Celi

Abstract read
In one paragraph

Article in Critical care (London, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Observational
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Hyperdynamic left ventricular ejection fraction is associated with higher mortality in COVID-19 patients.American heart journal plus : cardiology research and practice · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Joseph R PaonessaBeth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA, 02215, USA. jrpaonessa@gmail.com.
Thomas BrennanMassachusetts Institute of Technology, 32 Vassar Street, Cambridge, MA, 02139, USA. tombombadl@gmail.com.
Marco PimentelInstitute of Biomedical Engineering, Oxford University, Headington, Oxford, OX3 7DQ, UK. marco.and.pimentel@gmail.com.
Daniel SteinhausBeth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA, 02215, USA. dsteinha@bidmc.harvard.edu.
Mengling FengMassachusetts Institute of Technology, 32 Vassar Street, Cambridge, MA, 02139, USA. mornin@gmail.com.
Leo Anthony CeliBeth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA, 02215, USA. leoanthonyceli@yahoo.com.

Funding

Critical Care Informatics: Ethical considerations around the use and sharing of health-related dataR01EB017205 · NIBIB · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI CELI, LEO ANTHONY G, MARK, ROGER GREENWOOD · 2014 to 2021
$3.8M
NIBIB NIH HHS R01 EB017205NIBIB NIH HHS R01 EB017205-01A1
6 · The paper itself

Abstract

introductionLimited information exists on the etiology, prevalence, and significance of hyperdynamic left ventricular ejection fraction (HDLVEF) in the intensive care unit (ICU). Our aim in the present study was to compare characteristics and outcomes of patients with HDLVEF with those of patients with normal left ventricular ejection fraction in the ICU using a large, public, deidentified critical care database.

methodsWe conducted a longitudinal, single-center, retrospective cohort study of adult patients who underwent echocardiography during a medical or surgical ICU admission at the Beth Israel Deaconess Medical Center using the Multiparameter Intelligent Monitoring in Intensive Care II database. The final cohort had 2867 patients, of whom 324 had HDLVEF, defined as an ejection fraction >70%. Patients with an ejection fraction <55% were excluded.

resultsCompared with critically ill patients with normal left ventricular ejection fraction, the finding of HDLVEF in critically ill patients was associated with female sex, increased age, and the diagnoses of hypertension and cancer. Patients with HDLVEF had increased 28-day mortality compared with those with normal ejection fraction in multivariate logistic regression analysis adjusted for age, sex, Sequential Organ Failure Assessment score, Elixhauser score for comorbidities, vasopressor use, and mechanical ventilation use (odds ratio 1.38, 95% confidence interval 1.039-1.842, p =0.02).

conclusionsThe presence of HDLVEF portended increased 28-day mortality, and may be helpful as a gravity marker for prognosis in patients admitted to the ICU. Further research is warranted to gain a better understanding of how these patients respond to common interventions in the ICU and to determine if pharmacologic modulation of HDLVEF improves outcomes.

Indexed as

Hospital MortalityAgedAge FactorsBostonCohort StudiesCritical IllnessFemaleHumansHypertensionIntensive Care UnitsLongitudinal StudiesMaleMiddle AgedNeoplasmsRetrospective StudiesSex FactorsVasoconstrictor Agents

Identifiers

PMID26250903
PMCPMC4528812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.